mhuckman
- Pause
- 0 new message(s) are waiting
-
-
mhuckman
More on the $TEVA Ratiopharm tragic backstory. http://bit.ly/bH3lak (HT @steinerm )
Mar. 19 at 2:43 PM
-
mhuckman
FDA statement on the Boston Scientific $BSX implantable cardio defib recall. http://bit.ly/dCTttb $STJ $MDT
Mar. 19 at 2:31 PM
-
mhuckman
New FDA warning on high-dose Zocor. http://bit.ly/bBEaJw $MRK $PFE $AZN
Mar. 19 at 11:19 AM
-
mhuckman
I guess Merck is trying to put Schering-Plough's over-the-counter Claritin back on the map. $MRK
Mar. 19 at 8:29 AM
-
mhuckman
Here's the Merck/Idol PR $MRK http://bit.ly/dxEq6E
Mar. 19 at 8:27 AM
-
mhuckman
Merck $MRK hooks up w/American Idol judge Kara Dioguardi as Claritin pitchperson. People 2 submit videos 2 win 1-yr supply of Claritin.
Mar. 19 at 8:24 AM
-
mhuckman
Yanai to Kindler: "Dude, you're going down!" Alright, an imaginary conversation. http://bit.ly/a3lLZa $TEVA $PFE
Mar. 18 at 3:43 PM
-
mhuckman
CNBC's Hampton Pearson just pointed out generic drug maker Mylan $MYL trading @ a 3-yr high 2day, $TEVA shares @ an all-time high.
Mar. 18 at 3:28 PM
-
mhuckman
FDA expands Medicines Co $MDCO drug recall. http://bit.ly/d3uGvj
Mar. 18 at 2:48 PM
-
mhuckman
$TEVA North America CEO Bill Marth 2mrw on @CNBCSquawkST @ 9:05a ET-ish w/me live/exclusive from the Nasdaq re Ratiopharm deal & more. $PFE
Mar. 18 at 2:14 PM
-
mhuckman
Small co,but Somaxon $SOMX has reopened 4 trading after announcing FDA approval of its insomnia drug & is up 75%. Bouncing around a lot,tho.
Mar. 18 at 12:22 PM
-
mhuckman
AstraZeneca $AZN PR on Seroquel verdict. "Plaintiffs either already had diabetes or @ significantly incr risk b4 they 1st took Seroquel."
Mar. 18 at 10:39 AM
-
mhuckman
DJ: "NJ jury sides w/AstraZeneca in first Seroquel injury trial." $AZN
Mar. 18 at 10:30 AM
-
mhuckman
Aetna $AET canceling investor/analyst mtg in NYC 2mrw. Will do CC instead. Cites "current political environment." Wow.
Mar. 18 at 9:44 AM
-
mhuckman
JPMorgan calls $TEVA deal "significantly accretive," meaning it's gonna increase profits a lot more than expected.
Mar. 18 at 9:37 AM
-
mhuckman
At the Nasdaq again today. $TEVA up pre-market 2.3%. Not many trades, yet, tho.
Mar. 18 at 7:58 AM
-
mhuckman
Shlomo Yanai vs. Jeff Kindler. The bout goes to Yanai. $TEVA beats Pfizer $PFE in fight for Ratiopharm. $4.8B
Mar. 18 at 7:49 AM
-
mhuckman
Teva says it's buying Ratiopharm. $TEVA $PFE
Mar. 18 at 7:43 AM
-
mhuckman
BMO:More Biogen Idec $BIIB Tysabri PML cases will "make physicians/patients more cautious,expect treatment discontinuations 2 increase."
Mar. 18 at 7:40 AM
-
mhuckman
$PFE $JNJ $ELN Bloomberg: Phase 3 data 4 Alzheimer's drug Bap could be pushed back to '12. http://bit.ly/axoYB9 (via @adamfeuerstein)
Mar. 18 at 7:35 AM
-
mhuckman
RT @NYTimesDealBook: Teva to Take Over Ratiopharm, Report Says http://nyti.ms/ckL9qo $TEVA $PFE
Mar. 18 at 7:08 AM
-
mhuckman
Lilly $LLY issues PR on $75m drug heist. Lists 2 pages of affected lots. Should be @ lilly.com soon, if not now.
Mar. 17 at 4:50 PM
-
mhuckman
If you missed the Roche CEO interview & want to see it. $RHHBY $OSIP $LLY $AMLN $ALKS http://tinyurl.com/pmrhhbyceo
Mar. 17 at 2:59 PM
-
mhuckman
AP: J&J's revenue went down last year,but $JNJ Chmn & CEO Bill Weldon got an 11% raise to $25.6M.I don't think the co will be tweeting that.
Mar. 17 at 2:33 PM
-
mhuckman
For more info on the new fed breast cancer drug study you can go to www.ispy2.org $PFE $ABT $AMGN
Mar. 17 at 1:03 PM
-
mhuckman
Great study name. Feds launch "I-SPY-2" clinical trial 2 c which women might do best on 5 experimental breast cancer drugs. $PFE $ABT $AMGN
Mar. 17 at 12:56 PM
-
mhuckman
Abraxis $ABII says late-stage study of Abraxane in lung cancer met its goal. Submitting for late-breaker presentation at ASCO.
Mar. 17 at 9:30 AM
-
mhuckman
Live interview with Roche CEO Severin Schwan tomorrow @ 11:20a ET-ish. Day before analyst/investor mtg in NYC. $RHHBY $OSIP $LLY $AMLN $ALKS
Mar. 16 at 5:07 PM
-
mhuckman
Deutsche Bank's Barbara Ryan says $500m peak sales of $LLY Lilly libido underarm spray "quite feasible. Not spectacular,but a solid pickup."
Mar. 16 at 4:25 PM
-
mhuckman
Jon LeCroy @ Hapoalim Securities says MannKind being "a bit naive."He thinks FDA's questions "could doom" $MNKD's inhalable insulin Afrezza.
Mar. 16 at 1:56 PM
Pop out Stream
Keep the StockTwits stream handy without taking up valuable screen space. Create a mini pop out window of this stream.
Subcribe Via RSS
Get all the update information delivered directly to your web browser or newsreader.
-
-
- Sign up now
-
-
Badges
- StockTwitsTV
Suggested